New to Investing? This 1 Medical Stock Could Be the Perfect Starting Point
https://www.zacks.com/stock/news/2235993/new-to-investing-this-1-medical-stock-could-be-the-perfect-starting-point?cid=CS-ZC-FT-tale_of_the_tape|zacks_education_focus_list-2235993
Mar 05, 2024 - Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Focus List.
0
2 No-Brainer Biotech Stocks to Buy Right Now
https://www.fool.com/investing/2024/02/21/2-no-brainer-biotech-stocks-to-buy-right-now/?source=iedfolrf0000001
Feb 21, 2024 - These stocks are used to beating the market.
0
Novo Nordisk Has More Than Ozempic. One of Its Other Treatments Grew 393% Last Year.
https://www.fool.com/investing/2024/02/18/novo-nordisk-has-more-than-ozempic-one-of-its/?source=iedfolrf0000001
Feb 18, 2024 - It may be best known for its diabetes treatment, Ozempic, but Novo Nordisk has a host of other blockbuster drugs, too.
0
Why Novo Nordisk (NVO) is a Top Stock for the Long-Term
https://www.zacks.com/stock/news/2224747/why-novo-nordisk-nvo-is-a-top-stock-for-the-long-term?cid=CS-ZC-FT-tale_of_the_tape|zacks_education_focus_list-2224747
Feb 12, 2024 - The Zacks Focus List offers investors a way to easily find top-rated stocks and build a winning investment portfolio. Here's why you should take advantage.
0
Novo Nordisk's Magic Run Continues Even With Increasing Competition
https://www.fool.com/investing/2024/02/12/novo-nordisks-magic-run-continues-even-with/?source=iedfolrf0000001
Feb 12, 2024 - Novo Nordisk's Q4 earnings were rock solid as momentum in the diabetes and obesity markets continued to fuel growth.
0
Pharma Stock Roundup: AZN & LLY's Q4 Earnings, NVO, NVS & MRK's M&A Deals
https://www.zacks.com/stock/news/2224190/pharma-stock-roundup-azn-lly-s-q4-earnings-nvo-nvs-mrk-s-m-a-deals?cid=CS-ZC-FT-analyst_blog|stock_roundup-2224190
Feb 09, 2024 - Eli Lilly (LLY) and AstraZeneca (AZN) announce fourth-quarter results. Novo Nordisk (NVO), Merck (MRK) and Novartis (NVS) make M&A announcements.
0
Here's Why Merck, Eli Lilly, and Novo Nordisk Stocks Rose 11% Last Month
https://www.fool.com/investing/2024/02/08/heres-why-merck-eli-lilly-and-novo-nordisk-stocks/?source=iedfolrf0000001
Feb 08, 2024 - Investors are still excited about obesity treatments and weight-management drugs.
0
Novo Nordisk (NVO) to Acquire 3 Catalent Sites for $11B
https://www.zacks.com/stock/news/2221276/novo-nordisk-nvo-to-acquire-3-catalent-sites-for-11b?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2221276
Feb 05, 2024 - Novo Nordisk (NVO) will acquire Catalent's three manufacturing sites from Novo Holdings to expand its manufacturing capacity.
0
3 Reasons Growth Investors Will Love Novo Nordisk (NVO)
https://www.zacks.com/stock/news/2220495/3-reasons-growth-investors-will-love-novo-nordisk-nvo?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_11_growth-2220495
Feb 02, 2024 - Novo Nordisk (NVO) could produce exceptional returns because of its solid growth attributes.
0
Pharma Stock Roundup: PFE, MRK, NVO & SNY's Q4 Earnings, FDA Updates
https://www.zacks.com/stock/news/2220214/pharma-stock-roundup-pfe-mrk-nvo-sny-s-q4-earnings-fda-updates?cid=CS-ZC-FT-analyst_blog|stock_roundup-2220214
Feb 02, 2024 - Pfizer (PFE), Merck (MRK), Novartis (NVS), Novo Nordisk (NVO) and Sanofi (SNY) announce fourth-quarter and full-year 2023 results.
0